Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 5/24/2013 8:41:41 AM - Followers: 996 - Board type: Free - Posts Today: 11
PostSubject
#161569  Sticky Note In addition, Astellas will no longer fund future jq1234 05/23/13 05:22:29 PM
#161568  Sticky Note MRK drops Preladenant program in Parkinson’s disease after DewDiligence 05/23/13 05:13:29 PM
#161555  Sticky Note Novo Nordisk reports 8% weight loss in phase jbog 05/23/13 12:13:37 PM
#161552  Sticky Note LPTN - ASONEP Trial to Study Effects of CynicalTrader 05/23/13 10:41:23 AM
#161506  Sticky Note The S-4 for the PFE-ZTS swap has been filed: DewDiligence 05/22/13 01:04:59 PM
#161479  Sticky Note PTLA IPOs at $14.50/share (the midpoint of anticipated range): DewDiligence 05/22/13 09:01:52 AM
#161612   MACK -Merrimack completes patient enrollment in Phase 2 CynicalTrader 05/24/13 10:16:46 AM
#161611   So how does OGX-011 block the production of clusterin? acgood 05/24/13 08:41:41 AM
#161610   vin... thank you for your responsible response. honestabe13 05/24/13 08:08:24 AM
#161609   Astellas (ALPMY.PK) and Medivation (MDVN) say a marketing dav1234 05/24/13 08:01:29 AM
#161608   Elan (ELN) intends to issue $850M worth of dav1234 05/24/13 07:56:12 AM
#161607   Pfizer's (PFE) price target is hiked a buck dav1234 05/24/13 07:54:28 AM
#161606   Covidien's (COV) pharmaceuticals business, which it's spinning off dav1234 05/24/13 07:53:32 AM
#161605   The California Institute for Regenerative Medicine grants Sangamo dav1234 05/24/13 07:50:01 AM
#161604   Thanks very much for your input. Malyshek 05/24/13 06:06:53 AM
#161603   {{Loe says this asset is often overshadowed by vinmantoo 05/24/13 12:57:10 AM
#161602   Abe, jq1234 and others are correct that the vinmantoo 05/24/13 12:54:59 AM
#161601   the 'drug' does not claim to act on iandy 05/23/13 10:56:22 PM
#161598   $30 price target on OGXI. Double_Bagel 05/23/13 10:38:34 PM
#161595   MM-398 PII results... CynicalTrader 05/23/13 10:13:35 PM
#161594   Are you a MRK fan now?Yes, since the DewDiligence 05/23/13 10:10:40 PM
#161593   >>staving off macular degeneration biomaven0 05/23/13 09:59:11 PM
#161592   Also, there was also another OGXI related PR yesterday. Summer2762 05/23/13 09:28:15 PM
#161591   Re: OGXI Summer2762 05/23/13 09:24:46 PM
#161590   AVEOThe biomarker trials are a long shot.What do mcbio 05/23/13 08:49:00 PM
#161589   You wanted comments on the article. The main jq1234 05/23/13 08:47:55 PM
#161588   Abe, on CNBC today a panelist on a north40000 05/23/13 08:27:18 PM
#161587   jg where did i say it was honestabe13 05/23/13 08:17:01 PM
#161586   The biomarker trials are a long shot. NP1986 05/23/13 08:13:06 PM
#161585   Sure, I am not qualified. Did you even jq1234 05/23/13 08:07:26 PM
#161584   more bias with no scientific support. honestabe13 05/23/13 07:59:17 PM
#161583   Of course I was speaking of the Melanoma Checkpoint 05/23/13 07:52:59 PM
#161582   I agree Merck's Anti PD1 results are very Checkpoint 05/23/13 07:49:04 PM
#161581   jg... you did not address the science. honestabe13 05/23/13 07:49:03 PM
#161580   AVEOI am not entirely surprised. 1st line RCC mcbio 05/23/13 07:42:35 PM
#161579   I am not entirely surprised. 1st line RCC jq1234 05/23/13 07:32:39 PM
#161578   If someone cannot tell the article is a jq1234 05/23/13 07:22:14 PM
#161577   Medivir - positive Phase 1a data for MIV-711 mcbio 05/23/13 07:11:16 PM
#161576   Somehow I think anorexia/cachexia is not as big pcrutch 05/23/13 07:00:11 PM
#161575   AVEOIn addition, Astellas will no longer fund future mcbio 05/23/13 06:41:56 PM
#161574   Maybe they should beef up there pipeline of Checkpoint 05/23/13 06:39:32 PM
#161573   unbelieveble that 80 million dollars a year is drbio45 05/23/13 06:36:35 PM
#161572   Crutch, Dew, Iwfal, vin, Ex, etc... honestabe13 05/23/13 06:30:25 PM
#161571   Are you a MRK fan now? Since I jq1234 05/23/13 06:00:28 PM
#161570   I suspect consensus estimates for Lambrolizumab (anti-PD-1) are pcrutch 05/23/13 05:50:17 PM
#161569   In addition, Astellas will no longer fund future jq1234 05/23/13 05:22:29 PM
#161568   MRK drops Preladenant program in Parkinson’s disease after DewDiligence 05/23/13 05:13:29 PM
#161567   The FDA Responds To Steve Nissen's Criticism Of CynicalTrader 05/23/13 05:04:03 PM
#161566   Is there any vitamin or supplement recommended for Malyshek 05/23/13 04:46:04 PM
#161565   AVEO SEC FILING BTH 05/23/13 04:19:28 PM
#161564   The Alzheimer's piece in the jnj presentation was masterlongevity 05/23/13 03:48:34 PM
#161563   ariad up 16 per cent last 3 days thesaud 05/23/13 03:06:59 PM
#161562   Targretin doesn’t work in AD, as it turns out: DewDiligence 05/23/13 02:56:11 PM
#161561   LOL—I didn’t realize Matt had appended my tweet DewDiligence 05/23/13 02:45:24 PM
#161560   Hey, I didn't check twitter, but your tweet jq1234 05/23/13 01:34:06 PM
#161559   Proellex has been on life support for a DewDiligence 05/23/13 01:05:07 PM
PostSubject